请输入您要查询的百科知识：

　

词条 Prevention of dementia
释义

  1. Lifestyle

     Mental activity  Physical activity  Diet  Sleep pattern  Personality and Mental Health   Depression  

  2. Medication

     Hypertension  Anti-diabetic drugs  Steroid hormones  NSAIDs  Vaccine 

  3. See also

  4. References

  5. External links

{{Use dmy dates|date=April 2014}}

The aim of dementia prevention is to delay or prevent dementia. Dementia prevention is a global health priority [1][2][3] and as such requires a global response. Recent initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP)[4] which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory[5] a web-based data knowledge and exchange platform, which will collate and disseminate key dementia data from members states. Although there is no cure for dementia currently, it is well established that modifiable risk factors influence both the likelihood of developing dementia and the age at which it is developed.[6][7] Dementia can be prevented by reducing the risk factors for vascular disease[6][7][8] (e.g. diabetes, high blood pressure, obesity, smoking, and physical inactivity) and depression.[7][6] Livingstone et al. (2014)[6] conclude that more than a third dementia cases are theoretically preventable.

Lifestyle

Mental activity

{{Main|Brain fitness}}

"Use it or lose it" might be applied to the brain when it comes to dementia. Intellectual activities help keep the mind in shape in later years. Activities such as reading, learning a new language, playing cards and board games and playing a musical instrument can postpone the onset and slow the progression of both Alzheimer's and vascular dementia.[9][10] The risk decrease is proportional to frequency of activity,[9] with slower cognitive decline being associated with both late-life and early-life increased cognitive activity.[11]

Apart from spare time activities, a mentally demanding job may prevent dementia, especially during the thirties, forties and fifties.[9]

Mental activity may help to prevent dementia by building up a "brain reserve": additional connections between neurons are created which are more resistant to the deterioration seen in dementia.[9]

Physical activity

{{Main|Neurobiological effects of physical exercise}}

Since vascular dementia is the second most common form of dementia (after Alzheimer's disease), reducing the risk of cerebrovascular disease also reduces the risk of dementia.[12] Thus, physical exercise, having good blood cholesterol, healthy body weight and blood pressure lowers the risk of developing dementia.[9] An active lifestyle can almost halve the risk compared to a sedentary one.[9]

Results of one meta-analysis, which investigated the relationship between physical activity and risk of cognitive decline in people without dementia, showed exercise had a significant and consistent protective effect against cognitive decline, with high levels of physical activity being most protective.[13] Another meta-analysis showed that not only did aerobic exercise reduce the risk of dementia but it may also slow cognitive decline in those with dementia.[14]

The effect of physical activity is not limited to vascular effects. Physical activity can give rise to new neurons in the brain, as well as releasing a substance that can protect them.[9] The protein known as brain-derived neurotrophic factor (BDNF) is known to be important in the development, survival and plasticity of neurons. Regular exercise can boost BDNF levels by 2–3 times.[15]

Diet

Obesity increases the risk of any dementia and Alzheimer's disease in particular.[9] The effect of alcohol on the risk of dementia is a J curve:[16] high alcohol consumption increases the risk of dementia[17] while low alcohol consumption may be protective.[16][18] However, low alcohol consumption may not protect against vascular dementia and overall cognitive decline.[16] Moderate alcohol consumption can possibly reduce the risk of vascular disease and dementia because it can increase blood levels of HDL cholesterol and weakens blood-clotting agents such as fibrinogen, which offers some protection against heart attacks and small subclinical strokes that together can ultimately damage the brain.[19]

The effects of omega-3 fatty acid in the prevention of dementia is uncertain.[20] Vegetables and nuts may be of benefit,[9] because of their high content of polyunsaturated fats. Non-fish meat, on the other hand, increases the risk of Alzheimer's,[9] because of its high content of saturated fat. However, consumption of fish should be limited due to concerns over mercury poisoning, which could exacerbate the symptoms of dementia.

Niacin (vitamin B3) is also believed to prevent dementia as research shows those who have the highest levels of niacin in their blood, are believed to have the lowest risk of developing dementia or having cognitive decline. Niacin is involved with DNA synthesis and repair and also neural cell signaling, it improves circulation and reduces cholesterol levels. In order for niacin to have a positive effect on the brain, it is recommended that patients have 100 to 300 mg per day.[19]

There is evidence for an association between cognitive decline, homocysteine (Hcy) status, and vitamin B status relating especially to B12[21] and also to vitamins B6 and B9.[22] In particular, deficiency of vitamin B12 and/or of folate can cause an increase in Hcy plasma levels, which in turn leads to toxic effects on the vascular and nervous systems.[23]

Vitamin D deficiency correlates with cognitive impairment and dementia; however, the value of vitamin D substitution in cognitive impairment remains doubtful.[24][25][26]{{See also|Memory improvement#Diet}}

Sleep pattern

More than nine hours of sleep per day (including daytime napping) may be associated with an increased risk of dementia.[27] Lack of sleep may also increase risk of dementia by increasing beta-amyloid deposition.[28]

Personality and Mental Health

Being neurotic increases the risk of developing Alzheimer's, a type of dementia.[29][30] Neuroticism is associated with increased brain atrophy and cognitive impairment in life, while conscientiousness has a protective effect by preventing brain atrophy.[31]

Depression

Depressive symptoms can be a part of the clinical presentation of dementia, leading to debate as to whether depression is a cause or a symptom of dementia.[6] The evidence remains unclear. However, Livingstone et al. (2014)[6] report that it is "biologically plausible" that depression increases the risk of dementia. There is some evidence that late-life depression increases the risk of dementia however[32] suggesting treating depression in mid-life might delay or prevent dementia.

Medication

Hypertension

Some studies say Alzheimer's and other dementias may be caused by high blood pressure, since it can cause blood vessel damage through constriction.[33][34] The etiology of vascular dementia includes hypertension, and thus, lowering blood pressure with antihypertensives may have a positive effect in the prevention of dementia, just as physical activity.

However, one study failed to demonstrate a link between high blood pressure and developing dementia. The study, published in the Lancet Neurology journal of July 2008, found that blood pressure lowering medication did not reduce the incidence of dementia to a statistically significant degree. A prospective meta-analysis of the data from this study with other studies suggested that further research might be warranted.[35]

A study of participants in the Leisure World Cohort Study and The 90+ Study showed that people whose high blood pressure began in their 80s might be less likely to develop dementia than people who did not have high blood pressure.[36]

While the results of studies are somewhat inconsistent, it has been recommended that hypertension in mid-life (45–65 years) and older age (65+ years) should be actively treated to reduce the risk of dementia.[6]

Anti-diabetic drugs

Diabetes mellitus is a risk factor for vascular dementia, and is thus the risk is lowered with anti-diabetic drugs.[37]

Besides, Rosiglitazone (Avandia) improves memory and thinking ability for people with mild Alzheimer's disease. The mechanism of the effect may be the ability of the drug to reduce insulin resistance.[9] Thus, less insulin needs to be released to achieve its metabolic effects. Insulin in the bloodstream is a trigger of amyloid beta-production,[37][38] so decreased insulin levels decrease the level of amyloid beta. This leads to less formation of amyloid plaques seen in Alzheimer's disease.

Steroid hormones

Estrogen may also help in the prevention of dementia but cannot help when dementia is already present and when cognitive function is already impaired. It increases cerebral blood flow and is an anti-inflammatory agent, enhancing activity at the neuronal synapses in the brain. It may also help to increase brain activation in regions that are affected by dementia which is mainly the hippocampus region.[39] Recent evidence on the effects of estrogen do not allow for an unambiguous recommendation for estrogen supplementation and they indicate that the timing of estrogen supplementation may be important, with early postmenopausal use being preferable over its use later in life.[40][41]

NSAIDs

Non-steroidal anti-inflammatory drugs (NSAIDs) can decrease the risk of developing Alzheimer's and Parkinson's diseases.[9] The length of time needed to prevent dementia varies, but in most studies it is usually between 2 and 10 years.[42][43][44][45][46] Research has also shown that it must be used in clinically relevant dosages and that so called "baby aspirin" doses are ineffective at treating dementia.[47]

Alzheimer's disease causes inflammation in the neurons by its deposits of amyloid beta peptides and neurofibrillary tangles. These deposits irritate the body by causing a release of e.g. cytokines and acute phase proteins, leading to inflammation. When these substances accumulate over years they contribute to the effects of Alzheimer's.[48] NSAIDs inhibit the formation of such inflammatory substances, and prevent the deteriorating effects.[49][50][51]

Vaccine

There is as yet no vaccine against dementia.[9] It has been theorized that a vaccine could activate the body's own immune system to combat the beta amyloid plaques in Alzheimer's disease. One problem to overcome is overreaction from the immune system, leading to encephalitis.[9]

See also

  • Alzheimer's disease
  • Prevention of chronic traumatic encephalopathy
  • Prevention of concussions
  • Prevention of traumatic brain injury
  • Preventive medicine
  • Alcohol dementia

References

1. ^{{cite web|url=http://www.who.int/mental_health/neurology/dementia/action_plan_consultation/en/|title=Development of a draft global action plan on the public health response to dementia|website=World Health Organization|access-date=2017-10-31}}
2. ^{{cite web|url=https://worlddementiacouncil.org/|title=Home {{!}} World Dementia Council|website=worlddementiacouncil.org|access-date=2017-10-31}}
3. ^{{cite web|url=http://www.oecd.org/health/dementia.htm|title=Dementia - OECD|website=www.oecd.org|access-date=2017-10-31}}
4. ^{{cite web|url=https://coghealth.net.au/|title=International Research Network on Dementia Prevention|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=2017-10-31}}
5. ^{{cite web|url=http://www.who.int/mental_health/neurology/dementia/GDO/en/|title=The Global Dementia Observatory|website=World Health Organization|access-date=2017-10-31}}
6. ^1 2 3 4 5 6 {{cite journal|last=Livingston|first=Gill|last2=Sommerlad|first2=Andrew|last3=Orgeta|first3=Vasiliki|last4=Costafreda|first4=Sergi G|last5=Huntley|first5=Jonathan|last6=Ames|first6=David|last7=Ballard|first7=Clive|last8=Banerjee|first8=Sube|last9=Burns|first9=Alistair|title=Dementia prevention, intervention, and care|journal=The Lancet|volume=390|issue=10113|pages=2673–2734|doi=10.1016/s0140-6736(17)31363-6|pmid=28735855|year=2017}}
7. ^1 2 {{cite journal|last=Norton|first=Sam|last2=Matthews|first2=Fiona E|last3=Barnes|first3=Deborah E|last4=Yaffe|first4=Kristine|last5=Brayne|first5=Carol|title=Potential for primary prevention of Alzheimer's disease: an analysis of population-based data|journal=The Lancet Neurology|volume=13|issue=8|pages=788–794|doi=10.1016/s1474-4422(14)70136-x|pmid=25030513|year=2014}}
8. ^{{cite web|url=http://www.who.int/mediacentre/factsheets/fs362/en/|title=WHO Media centre fact sheets: Dementia. Fact sheet N°362|date=April 2012|accessdate=21 January 2015}}
9. ^1 2 3 4 5 6 7 8 9 10 11 12 13 {{cite web |url= http://www.wvdhhr.org/bph/oehp/hsc/dementia/prevent.htm |title=Prevention of Dementia |work=Dementia: The Growing Crisis in West Virginia |date=February 2005 |first1=Eugenia |last1=Thoenen |author2=Health Statistics Center Statistical Staff |first3=James |last3=Doria |first4=Fred |last4=King |first5=Thomas N. |last5=Leonard |first6=Tom |last6=Light |first7=Philip |last7=Simmons |accessdate=2 October 2009}}
10. ^{{cite journal|date=2013-11-06|title=Bilingualism delays age at onset of dementia, independent of education and immigration status|journal=Neurology|volume=81|issue=22|pages=1938–1944|doi=10.1212/01.wnl.0000436620.33155.a4 |pmid=24198291|last1=Alladi|first1=S.|last2=Bak|first2=T. H.|last3=Duggirala|first3=V.|last4=Surampudi|first4=B.|last5=Shailaja|first5=M.|last6=Shukla|first6=A. K.|last7=Chaudhuri|first7=J. R.|last8=Kaul|first8=S.}}
11. ^{{cite web |url=http://neurology.org/content/early/2013/07/03/WNL.0b013e31829c5e8a |title=Life-span cognitive activity, neuropathologic burden, and cognitive aging (Abstract)|last=Wilson |first=Robert S.|date=3 July 2013 |website=Neurology |archiveurl=https://www.webcitation.org/6Ht0Ia2PN |archivedate=5 July 2013 |display-authors=etal}} Explained by {{cite web |url=http://blogs.smithsonianmag.com/science/2013/07/being-a-lifelong-bookworm-may-keep-you-sharp-in-old-age/ |title=Being a Lifelong Bookworm May Keep You Sharp in Old Age |last=Koren |first=Marina |date=23 July 2013 |website=Smithsonian |archiveurl=https://www.webcitation.org/6Ht0xyPkH |archivedate=5 July 2013 }}
12. ^{{cite journal|last=Kuźma|first=Elżbieta|last2=Lourida|first2=Ilianna|last3=Moore|first3=Sarah F.|last4=Levine|first4=Deborah A.|last5=Ukoumunne|first5=Obioha C.|last6=Llewellyn|first6=David J.|date=August 2018|title=Stroke and dementia risk: A systematic review and meta-analysis|url=https://www.alzheimersanddementia.com/article/S1552-5260(18)33250-3/abstract|journal=Alzheimer's & Dementia|language=English|volume=0|issue=11|pages=1416–1426|doi=10.1016/j.jalz.2018.06.3061|pmid=30177276|pmc=6231970|issn=1552-5260}}
13. ^{{cite journal|last=Sofi|first=F.|last2=Valecchi|first2=D.|last3=Bacci|first3=D.|last4=Abbate|first4=R.|last5=Gensini|first5=G. F.|last6=Casini|first6=A.|last7=Macchi|first7=C.|date=January 2011|title=Physical activity and risk of cognitive decline: a meta-analysis of prospective studies|journal=Journal of Internal Medicine|volume=269|issue=1|pages=107–117|doi=10.1111/j.1365-2796.2010.02281.x|issn=1365-2796|pmid=20831630}}
14. ^{{cite journal|last=Ahlskog|first=J. Eric|last2=Geda|first2=Yonas E.|last3=Graff-Radford|first3=Neill R.|last4=Petersen|first4=Ronald C.|title=Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging|journal=Mayo Clinic Proceedings|volume=86|issue=9|pages=876–884|doi=10.4065/mcp.2011.0252|pmid=21878600|pmc=3258000|year=2011}}
15. ^{{cite web|last1=Jones|first1=Hilary|title=Dr|url=http://www.telecare24.co.uk/blog/dr-hilary-jones-preventing-dementia-exercise/|website=telecare24/co.uk}}
16. ^1 2 {{cite journal |vauthors=Chen JH, Lin KP, Chen YC |title=Risk factors for dementia |journal=J. Formos. Med. Assoc. |volume=108 |issue=10 |pages=754–64 |date=October 2009 |pmid=19864195 |doi=10.1016/S0929-6646(09)60402-2 |url=}}
17. ^{{cite journal |author=Grønbaek M |title=The positive and negative health effects of alcohol- and the public health implications |journal=Journal of Internal Medicine |volume=265 |issue=4 |pages=407–20 |date=April 2009 |pmid=19298457 |doi=10.1111/j.1365-2796.2009.02082.x |url=}}
18. ^{{cite journal |vauthors=Peters R, Peters J, Warner J, Beckett N, Bulpitt C |title=Alcohol, dementia and cognitive decline in the elderly: a systematic review |journal=Age and Ageing |volume=37 |issue=5 |pages=505–12 |year=2008 |pmid=18487267 |doi=10.1093/ageing/afn095 |url=}}
19. ^1 {{cite journal |author= Robert, Levine |title= Defying dementia: understanding and preventing Alzheimer's and related disorders |journal= Westport: Conn: Praeger |year= 2006}}
20. ^{{cite journal |vauthors=Cederholm T, Palmblad J |title=Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? |journal=Current Opinion in Clinical Nutrition and Metabolic Care|volume=13 |issue=2 |pages=150–5 |date=March 2010 |pmid=20019606|doi=10.1097/MCO.0b013e328335c40b |url=}}
21. ^{{cite journal |vauthors=Gröber U, Kisters K, Schmidt J |title=Neuroenhancement with vitamin B12-underestimated neurological significance |journal=Nutrients |volume=5 |issue=12 |pages=5031–45 |year=2013 |pmid=24352086 |pmc=3875920 |doi=10.3390/nu5125031 |type=Review}}
22. ^{{cite journal |vauthors=Reay JL, Smith MA, Riby LM |title=B vitamins and cognitive performance in older adults: review |journal=ISRN Nutrition |volume=2013 |issue= |pages=1–7 |year=2013 |pmid=24959550 |pmc=4045270 |doi=10.5402/2013/650983 |type=Review}}
23. ^{{cite journal |vauthors=Ansari R, Mahta A, Mallack E, Luo JJ |title=Hyperhomocysteinemia and neurologic disorders: a review |journal=Journal of Clinical Neurology (Seoul, Korea) |volume=10 |issue=4 |pages=281–8 |year=2014 |pmid=25324876 |pmc=4198708 |doi=10.3988/jcn.2014.10.4.281 |type=Review}}
24. ^{{cite journal |vauthors=Schlögl M, Holick MF |title=Vitamin D and neurocognitive function |journal=Clinical Interventions in Aging |volume=9 |issue= |pages=559–68 |year=2014 |pmid=24729696 |pmc=3979692 |doi=10.2147/CIA.S51785 |type=Review}}
25. ^{{cite journal |vauthors=Etgen T, Sander D, Bickel H, Sander K, Förstl H |title=Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis |journal=Dementia and Geriatric Cognitive Disorders |volume=33 |issue=5 |pages=297–305 |year=2012 |pmid=22759681 |doi=10.1159/000339702 |type=Review}}
26. ^{{cite journal |vauthors=Dickens AP, Lang IA, Langa KM, Kos K, Llewellyn DJ |title=Vitamin D, cognitive dysfunction and dementia in older adults |journal=CNS Drugs |volume=25 |issue=8 |pages=629–39 |year=2011 |pmid=21790207 |doi=10.2165/11593080-000000000-00000 |pmc=5097668}}
27. ^{{cite journal |doi= 10.1111/j.1468-1331.2009.02618.x |pmid=19473367 |year=2009 |last1=Benito-León |first1=J |last2=Bermejo-Pareja |first2=F |last3=Vega |first3=S |last4=Louis |first4=ED |title=Total daily sleep duration and the risk of dementia: a prospective population-based study |volume=16 |issue=9 |pages=990–7 |journal=European Journal of Neurology}}
28. ^{{cite web|url=http://www.medicalnewstoday.com/articles/267710.php|title=Lack of sleep may increase Alzheimer's risk|work=Medical News Today|accessdate=21 March 2016}}
29. ^{{cite web|url=http://www.alzheimersresearchuk.org/news-detail/11160/Neuroticism-and-other-personality-traits-in-midlife-linked-to-Alzheimers-risk/|title=Neuroticism and other personality traits in midlife linked to Alzheimer's risk - Alzheimer's Research UK|date=1 October 2014|publisher=}}
30. ^{{cite web|url=http://www.webmd.com/women/news/20141001/jealous-moody-women-may-face-higher-alzheimers-risk-study-says|title=Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says|publisher=}}
31. ^{{cite journal|title=Exploring the relationship between personality and regional brain volume in healthy aging| pmc=2891197 | pmid=20036035 | doi=10.1016/j.neurobiolaging.2009.12.009| volume=32| issue=12 | date=December 2011|vauthors=Jackson J, Balota DA, Head D | journal=Neurobiol. Aging| pages=2162–71}}
32. ^{{cite journal|last=Diniz|first=Breno S.|last2=Butters|first2=Meryl A.|last3=Albert|first3=Steven M.|last4=Dew|first4=Mary Amanda|last5=Reynolds|first5=Charles F.|date=May 2013|title=Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies|journal=The British Journal of Psychiatry|volume=202|issue=5|pages=329–335|doi=10.1192/bjp.bp.112.118307|issn=1472-1465|pmc=3640214|pmid=23637108}}
33. ^{{cite news|url=http://news.bbc.co.uk/1/hi/health/7528539.stm|title=Blood pressure drug dementia hope|date=28 July 2008|accessdate=2 October 2009|publisher=BBC News}}
34. ^{{cite press release|title=Blood Pressure Drugs May Protect Against Alzheimer's|date=27 July 2008|publisher=Boston University School of Medicine|url=https://www.washingtonpost.com/wp-dyn/content/article/2008/07/27/AR2008072701213.html|accessdate=2 October 2009}}
35. ^{{cite journal |author=Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C; HYVET investigators |title=Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial |journal=Lancet Neurol |volume=7 |issue=8 |pages=683–9 |date=August 2008 |doi=10.1016/S1474-4422(08)70143-1 |author-separator= |pmid=18614402 |deadurl=no }}
36. ^{{cite journal |author=María M. Corrada, Kathleen M. Hayden, Annlia Paganini-Hill, Szofia S. Bullain, Jaime DeMoss, Colette Aguirre, Ron Brookmeyer, Claudia H. Kawas |title=Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study|journal=Alzheimer's & Dementia|volume=7|issue=8|pages=683–9|date=January 16, 2017|doi=10.1016/S1474-4422(08)70143-1 |author-separator= |pmid=18614402|url=http://www.alzheimersanddementia.com/article/S1552-5260(16)32962-4/pdf}}
37. ^1 {{cite press release |title=Diabetes and Alzheimer's linked |publisher=Mayo Clinic |date=6 November 2008 |url=http://www.mayoclinic.com/health/diabetes-and-alzheimers/AZ00050 |accessdate=2 October 2009}}
38. ^{{cite web|url=http://www.webmd.com/alzheimers/guide/20050808/obesity-alzheimers-risk|title=Obesity Today, Alzheimer's Disease Tomorrow?|work=WebMD|accessdate=21 March 2016}}
39. ^{{cite journal |author= Eileen M., Welsh |title= Focus on Alzheimer's disease research |journal= Nova Biomedical Books |pages= 699 |year= 2003}}
40. ^{{cite journal |vauthors=Simpkins JW, Perez E, Wang X, Yang S, Wen Y, Singh M |title=The potential for estrogens in preventing Alzheimer's disease and vascular dementia |journal=Therapeutic Advances in Neurological Disorders |volume=2 |issue=1 |pages=31–49 |year=2009 |pmid=19890493 |pmc=2771945 |doi=10.1177/1756285608100427 |url=}}
41. ^{{cite web |authors=Anderson P |title=Timing of Hormone Therapy May Affect Alzheimer's Prevention |publisher=Medscape |date=25 October 2012 }}
42. ^{{cite journal |pmid=18509093 |year=2008 |last1=Szekely |first1=CA |last2=Green |last3=Breitner |last4= Østbye |last5=Beiser |last6=Corrada |last7=Dodge |last8=Ganguli |last9=Kawas |title=No advantage of "Aβ42-lowering" NSAIDs for prevention of AD in six pooled cohort studies |volume=70 |issue=24 |pages=2291–8 |doi=10.1212/01.wnl.0000313933.17796.f6 |journal=Neurology |first2=RC |first3=JC |first4=T |first5=AS |first6=MM |first7=HH |first8=M |first9=CH |pmc=2755238 }}
43. ^{{cite journal |pmid=15084783 |year=2004 |last1=Cornelius |first1=C |last2=Fastbom |last3=Winblad |last4=Viitanen |title=Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population |volume=23 |issue=3 |pages=135–43 |doi=10.1159/000075957 |journal=Neuroepidemiology |first2=J |first3=B |first4=M}}
44. ^{{cite journal |pmid=12869452 |doi=10.1136/bmj.327.7407.128 |year=2003 |last1=Etminan |first1=M |last2=Gill |last3=Samii |title=Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies |volume=327 |issue=7407 |pages=128 |journal=BMJ |first2=S |first3=A |pmc=165707}}
45. ^{{cite journal |pmid=12827329 |year=2003 |last1=Nilsson |first1=SE |last2=Johansson |last3=Takkinen |last4=Berg |last5= Zarit |last6=Mcclearn |last7=Melander |title=Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years |volume=59 |issue=4 |pages=313–9 |doi=10.1007/s00228-003-0618-y |journal=European Journal of Clinical Pharmacology |first2=B |first3=S |first4=S |first5=S |first6=G |first7=A}}
46. ^{{cite journal |pmid=10851364 |year=2000 |last1=Anthony |first1=JC |last2= Breitner |last3=Zandi |last4=Meyer |last5=Jurasova |last6=Norton |last7=Stone |title=Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study |volume=54 |issue=11 |pages=2066–71 |journal=Neurology |first2=JC |first3=PP |first4=MR |first5=I |first6=MC |first7=SV |doi=10.1212/wnl.54.11.2066}}
47. ^{{cite journal |pmid=18068522 |year=2008 |last1=Ad2000 Collaborative |first1=Group |last2=Bentham |last3=Gray |last4=Sellwood |last5=Hills |last6=Crome |last7=Raftery |title=Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial |volume=7 |issue=1 |pages=41–9 |doi= 10.1016/S1474-4422(07)70293-4 |journal=Lancet Neurology |first2=P |first3=R |first4=E |first5=R |first6=P |first7=J}}
48. ^{{cite journal |pmid=10858586 |year=2000 |last1=Akiyama |first1=H |last2=Barger |last3=Barnum |last4=Bradt |last5=Bauer |last6=Cole |last7=Cooper |last8=Eikelenboom |last9=Emmerling |title=Inflammation and Alzheimer's disease |volume=21 |issue=3 |pages=383–421 |journal=Neurobiology of Aging |doi=10.1016/S0197-4580(00)00124-X |first2=S |first3=S |first4=B |first5=J |first6=GM |first7=NR |first8=P |first9=M |pmc=3887148 }}
49. ^{{cite journal |pmid=16386371 |year=2006 |last1=Tortosa |first1=E |last2=Avila |last3=Pérez |title= Acetylsalicylic acid decreases tau phosphorylation at serine 422 |volume=396 |issue=1 |pages=77–80 |doi=10.1016/j.neulet.2005.11.066 |journal=Neuroscience Letters |first2=J |first3=M}}
50. ^{{cite journal |pmid=16125740 |year=2005 |last1=Hirohata |first1=M |last2=Ono |last3=Naiki |last4=Yamada |title=Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro |volume=49 |issue=7 |pages=1088–99 |doi=10.1016/j.neuropharm.2005.07.004 |journal=Neuropharmacology |first2=K |first3=H |first4=M}}
51. ^{{cite journal |pmid= 11711868 |year=2001 |last1=Thomas |first1=T |last2=Nadackal |last3=Thomas |title=Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation |volume=12 |issue= 15 |pages=3263–7 |journal=NeuroReport |doi=10.1097/00001756-200110290-00024 |first2= TG |first3= K}}

External links

  • {{cite journal | title = Dementia prevention, intervention, and care | url = http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31363-6/ | last = Livingston | first = Gill | others = et al. | journal = The Lancet | volume = 390 | issue = 10113 | pages = 2673–2734 | date = 19 July 2017 | doi = 10.1016/S0140-6736(17)31363-6 | pmid = 28735855 }}

5 : Cognitive disorders|Prevention|Neurology|Neuropsychology|Dementia
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/11/10 15:03:33